Teva Pharmaceuticals USA, Inc recalls Isotretinoin Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Superpotent Drug: The 3-month stability result for assay was found to be above specification limit
- Products
-
- Isotretinoin Capsules
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 5,304 3x10-cartons
- About this recall
- Isotretinoin Capsules, USP 40mg, 30-count 3x10 blister packs per carton, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054. Blister Pack NDC 0591-2436-45, Carton NDC 0591-2436-15